Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Diabetes/Metabolism Research and Reviews
|
September 26, 2012
Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study)
Shin-ichi Harashima, Toru Fukushima, Mayumi Sasaki, et al.
Endocrinology
|
December 24, 2014
Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion
Kanako Iwasaki, Norio Harada, Kazuki Sasaki, et al.
Diabetology International
|
August 18, 2020
Medical nutrition therapy and dietary counseling for patients with diabetes-energy, carbohydrates, protein intake and dietary counseling
Toshimasa Yamauchi, Hideki Kamiya, Kazunori Utsunomiya, et al.
Molecular Endocrinology (Baltimore, Md.)
|
February 14, 2006
Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion
Katsushi Tsukiyama, Yuichiro Yamada, Chizumi Yamada, et al.
The Journal of Endocrinology
|
June 4, 2014
KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state
Hidetada Ogata, Yusuke Seino, Norio Harada, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
February 7, 2018
Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain
Ryuya Maekawa, Hidetada Ogata, Masatoshi Murase, et al.
Diabetology & Metabolic Syndrome
|
March 1, 2016
Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial
Yaeko Kondo, Norio Harada, Akihiro Hamasaki, et al.
Journal of Clinical Medicine Research
|
November 15, 2024
Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study
Naoki Wada, Takaaki Murakami, Muhammad Fauzi, et al.
Journal of Diabetes and Its Complications
|
January 24, 2015
Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients
Daisuke Yabe, Akira Kuroe, Koin Watanabe, et al.
Diabetes
|
August 4, 2011
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice
Tatsuhito Himeno, Hideki Kamiya, Keiko Naruse, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Diabetes/Metabolism Research and Reviews
|
September 26, 2012
Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study)
Shin-ichi Harashima, Toru Fukushima, Mayumi Sasaki, et al.
Endocrinology
|
December 24, 2014
Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion
Kanako Iwasaki, Norio Harada, Kazuki Sasaki, et al.
Diabetology International
|
August 18, 2020
Medical nutrition therapy and dietary counseling for patients with diabetes-energy, carbohydrates, protein intake and dietary counseling
Toshimasa Yamauchi, Hideki Kamiya, Kazunori Utsunomiya, et al.
Molecular Endocrinology (Baltimore, Md.)
|
February 14, 2006
Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion
Katsushi Tsukiyama, Yuichiro Yamada, Chizumi Yamada, et al.
The Journal of Endocrinology
|
June 4, 2014
KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state
Hidetada Ogata, Yusuke Seino, Norio Harada, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
February 7, 2018
Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain
Ryuya Maekawa, Hidetada Ogata, Masatoshi Murase, et al.
Diabetology & Metabolic Syndrome
|
March 1, 2016
Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial
Yaeko Kondo, Norio Harada, Akihiro Hamasaki, et al.
Journal of Clinical Medicine Research
|
November 15, 2024
Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study
Naoki Wada, Takaaki Murakami, Muhammad Fauzi, et al.
Journal of Diabetes and Its Complications
|
January 24, 2015
Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients
Daisuke Yabe, Akira Kuroe, Koin Watanabe, et al.
Diabetes
|
August 4, 2011
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice
Tatsuhito Himeno, Hideki Kamiya, Keiko Naruse, et al.
Page
of 11